Skip to main content
Cowhey Center on Global Transformation CCGT

Paul Niehaus

Paul Niehaus
David Mallery was the co-founder and CEO of Paradigm Diagnostics and Viomics, now part of Exact Sciences. He was also the co-founder and president of the Molecular Profiling Institute, now part of Caris Life Sciences. Mallery also helped co-found and serves as president of the International Genomics Consortium (IGC) that incubates innovative biotech companies and helped lead efforts to land and expand IGC’s role as the founding Biospecimen Core Resource and Tissue Source Site network for the National Cancer Institute’s flagship project – The Cancer Genome Atlas (TCGA). He was formerly the principal venture analyst for the Calvert Group’s venture and equity fund investments and has been an investment advisor on numerous biotech investments through exit. Mallery earned a BA in Human Biology and Studio Art from Stanford University, is a member of the Colorado Bar Association, is an active member of YPO, and is a life member of the Council on Foreign Relations.